Document rx9Eb8mE4XNoRNGdDXKv389pE

July 2, 1981 Shell Development Company One Shell Plaza P O 8ox 4320 Houston Texas 77210 V RECEIVED jun 5J902 Dr. Carol R. Stack., Ph.D. Chemical Maaufacturers Association 2501 M Street, NW Washington, D.C. 20037 Dear Dr. Stack: This is in response to your letter of May 13, and confirms our recent phone conversation regarding Shell's participation in the VCM epide miology update monitoring. Our Corporate Medical Department has named D. A. McCraw, Senior Specialist/Epidemiology, to assist in this activity. Ms. McCraw can be reached at 713-241-6078, or by mail at the above address. Unfortunately, due to certain internal constraints Ms. McCraw will not be able to devote an unlimited amount of time to the monitoring. However, in view of the fact that at least two other very well qualified individuals will also be involved, it is felt that the monitoring effort should be adquace to insure a properly conducted sLudy. Best regards. Yours truly, VLK/jf V. L. Kirkland, Ph.D. Senior Research Toxicologist CMA 101476